Unknown OBSERVATIONAL NCT04423562

PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices (PRO-VAD)

Investigation of the Prognostic Value of pVO2 in Recipients of Left Ventricular Assist Devices

Sponsor: Rigshospitalet, Denmark

Conditions Advanced Heart Failure Left Ventricular Assist Device Prognosis

Updated 5 times since 2020 Last updated: Jun 7, 2020 Started: Apr 10, 2020 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04423562, this observational or N/A phase trial focuses on Advanced Heart Failure and Left Ventricular Assist Device and remains ongoing. Sponsored by Rigshospitalet, Denmark, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Recruiting
Jul 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark